News about Global Pharma

Bormioli Pharma Announces Winner of Call4Ideas Launched in Collaboration with Desall

The competition, which aimed to innovate traditional CRC locking systems through the introduction of biometric technologies, attracted 37 design proposals.

Global Pharma | 16/10/2023 | By Manvi |  589

SGD Pharma Expands Sterinity Glass Vials for Parenteral Pharmaceutical Applications

The launch of additional sizes 10H*ml and 20H ml in tray is advantageous to customers who will benefit from increased flexibility as a result of the extended portfolio.

Global Pharma | 16/10/2023 | By Manvi |  861

BioMap Collaborates with Sanofi to Co-Develop AI Modules for Biotherapeutic Drug Discovery

BioMap is eligible to receive payments of more than $1 billion based on achievement of preclinical development, clinical development, regulatory, and commercial milestones.

Global Pharma | 11/10/2023 | By Manvi |  1079

Strides Gets USFDA Approval for Icosapent Ethyl Capsules

The product complements Strides' range of approved soft gelatin capsules.

Global Pharma | 09/10/2023 | By Manvi |  626

Marksans Pharma Announces US FDA Approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg

This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR DelayedRelease Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals LP.

Global Pharma | 09/10/2023 | By Manvi |  602

Sun Pharma to Acquire 38% Stake in EzeRx Health Tech for Rs 29 Crore

Sun Pharma will acquire a 37.76% equity shareholding in EzeRx at a cost of Rs 28.69 crore, according to a stock exchange filing.

Global Pharma | 09/10/2023 | By Manvi |  895

REFCOLD India 2023 Sets to Showcase India's Prowess in Refrigeration and Cold Chain Industry Map

The collaboration encompasses the presentation of cutting-edge technological solutions, forging new partnerships and unlocking business opportunities.

Global Pharma | 09/10/2023 | By Manvi |  406

Granules India's Losartan and Hydrochlorothiazide Tablets Gets US FDA Approval

These approved tablets are deemed bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Hyzaar Tablets, marketed by Organon LLC.

Global Pharma | 03/10/2023 | By Manvi |  1032

Lupin Acquires Five Brands from Menarini

The brands are Piclin (Picosulphate Sodium), Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and Distaclor (Cefaclor).

Global Pharma | 26/09/2023 | By Manvi |  935

Croatian Pharma Producer JGL Completes 53 Million Euro Investment Project

The project, named INTEGRA, included construction of high-tech facilities on two locations near Rijeka, and took three years to complete, the company said.

Global Pharma | 26/09/2023 | By Manvi |  960